Featured

Dr. Mia Talmor Joins the MTF Biologics Board of Directors

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by honoring... Read more »

Highmark Health Appoints Craig Riner as Executive Vice President, Chief Marketing Officer

Highmark Health today announced that Craig Riner has been appointed Executive Vice President and Chief Marketing... Read more »

Orchestra BioMed Appoints David Pacitti To Board

NEW HOPE, Pa., March 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, a biomedical company... Read more »

citybiz
Gain exposure through our multi-channel news platform.

NRx Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

NRx Pharmaceuticals Announces Reverse Stock Split

Tonix Pharmaceuticals Prices of $4.4 Million Registered Direct Offering

Tevogen Bio Announces Series A-1 Preferred Stock Investment

Carmell Closes Sale of Axolotl Biologix

BD Named Among Fortune’s Most Innovative Companies

Virpax Pharmaceuticals Reports 2023 Year-End Results

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

Healthcare Advisory Firm Coker Group Sells Majority Stake to PE Firm Trinity Hunt Partners

NRx Pharmaceutical’s Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK

NRx Pharmaceuticals Announces Results of Shareholder Meeting

Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

One America News Interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals

Kanvas Biosciences Closes on $3.9 Million

AstraZeneca to Acquire Fusion Pharmaceuticals

Madrigal Pharmaceuticals Prices of Upsized $600 Million Public Offering